Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.
A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Interim President Michael I. Kotlikoff invoked history – Cornell’s and his own – in his first State of the University address, delivered Oct. 18 in Call Auditorium during the Trustee-Council Annual Meeting.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
